Cargando…
301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472540/ http://dx.doi.org/10.1016/j.annonc.2022.07.435 |
_version_ | 1784789323856478208 |
---|---|
author | Valente, A.C. Lopes Almeida, C. Costa, M.J. Nogueira Costa, I.C. Reis, J.S. Freitas, M.C.B. Teixeira, C.M. Gonçalves, M.V. Fernandes, A.C. Costa, A.S.A. Caeiro, C.L.B. Osório, L. Augusto, I.M. Barbosa, M. |
author_facet | Valente, A.C. Lopes Almeida, C. Costa, M.J. Nogueira Costa, I.C. Reis, J.S. Freitas, M.C.B. Teixeira, C.M. Gonçalves, M.V. Fernandes, A.C. Costa, A.S.A. Caeiro, C.L.B. Osório, L. Augusto, I.M. Barbosa, M. |
author_sort | Valente, A.C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9472540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94725402022-09-14 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic Valente, A.C. Lopes Almeida, C. Costa, M.J. Nogueira Costa, I.C. Reis, J.S. Freitas, M.C.B. Teixeira, C.M. Gonçalves, M.V. Fernandes, A.C. Costa, A.S.A. Caeiro, C.L.B. Osório, L. Augusto, I.M. Barbosa, M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472540/ http://dx.doi.org/10.1016/j.annonc.2022.07.435 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Valente, A.C. Lopes Almeida, C. Costa, M.J. Nogueira Costa, I.C. Reis, J.S. Freitas, M.C.B. Teixeira, C.M. Gonçalves, M.V. Fernandes, A.C. Costa, A.S.A. Caeiro, C.L.B. Osório, L. Augusto, I.M. Barbosa, M. 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic |
title | 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic |
title_full | 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic |
title_fullStr | 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic |
title_full_unstemmed | 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic |
title_short | 301P Hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during COVID-19 pandemic |
title_sort | 301p hypofractionated radiotherapy for the treatment of newly diagnosed high-grade gliomas in younger and good performance status patients during covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472540/ http://dx.doi.org/10.1016/j.annonc.2022.07.435 |
work_keys_str_mv | AT valenteac 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT lopesalmeidac 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT costamj 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT nogueiracostaic 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT reisjs 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT freitasmcb 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT teixeiracm 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT goncalvesmv 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT fernandesac 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT costaasa 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT caeiroclb 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT osoriol 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT augustoim 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic AT barbosam 301phypofractionatedradiotherapyforthetreatmentofnewlydiagnosedhighgradegliomasinyoungerandgoodperformancestatuspatientsduringcovid19pandemic |